About Antheia
Antheia is a company based in Palo Alto (United States) founded in 2013 by Christina Smolke and Kristy Hawkins.. Antheia has raised $152.37 million across 12 funding rounds from investors including SVB, HHS and Oxford Finance. The company has 50 employees as of December 31, 2022. Antheia offers products and services including Biosynthetic APIs and Key Starting Materials (KSMs). Antheia operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
- Headquarter Palo Alto, United States
- Employees 50 as on 31 Dec, 2022
- Founders Christina Smolke, Kristy Hawkins
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Antheia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$152.37 M (USD)
in 12 rounds
-
Latest Funding Round
$56 M (USD), Series C
Jun 03, 2025
-
Investors
SVB
& 13 more
-
Employee Count
50
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antheia
Antheia offers a comprehensive portfolio of products and services, including Biosynthetic APIs and Key Starting Materials (KSMs). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Produces active ingredients via synthetic biology for drug manufacturing
Engineers yeast to create essential precursors for pharmaceuticals efficiently
Unlock access to complete
Funding Insights of Antheia
Antheia has successfully raised a total of $152.37M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $56 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series C — $56.0M
-
First Round
First Round
(13 Mar 2015)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Series C - Antheia | Valuation | Global Health Investment | |
| Jul, 2024 | Amount | Series B - Antheia | Valuation | In-Q-Tel , Echo |
|
| Jun, 2022 | Amount | Debt – Venture - Antheia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Antheia
Antheia has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, HHS and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm
|
Founded Year | Domain | Location | |
|
Echo Investment Capital is engaged in multi-strategy investment management.
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Antheia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Antheia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Antheia Comparisons
Competitors of Antheia
Antheia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Antheia
Frequently Asked Questions about Antheia
When was Antheia founded?
Antheia was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Antheia located?
Antheia is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Who is the current CEO of Antheia?
Christina Smolke is the current CEO of Antheia. They have also founded this company.
Is Antheia a funded company?
Antheia is a funded company, having raised a total of $152.37M across 12 funding rounds to date. The company's 1st funding round was a Debt – Venture of $40M, raised on Mar 13, 2015.
How many employees does Antheia have?
As of Dec 31, 2022, the latest employee count at Antheia is 50.
What does Antheia do?
Antheia was founded in 2013 in Palo Alto, United States, within the synthetic biology sector. Medicines are developed through the integration of synthetic biology, informatics, and fermentation technologies. Yeast cells are engineered to yield plant-based medicinal products. Operations center on creating natural compounds for therapeutic applications, with a focus on scalable production methods.
Who are the top competitors of Antheia?
Antheia's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
What products or services does Antheia offer?
Antheia offers Biosynthetic APIs and Key Starting Materials (KSMs).
Who are Antheia's investors?
Antheia has 14 investors. Key investors include SVB, HHS, Oxford Finance, In-Q-Tel, and Echo Investment Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.